UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000028385
Receipt number R000032490
Scientific Title Surgically induced changes in astigmatism and shape of total and posterior cornea after nasal versus temporal clear corneal incision (CCI) cataract surgery: a prospective randomized clinical study.
Date of disclosure of the study information 2017/07/26
Last modified on 2018/06/22 12:09:20

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Surgically induced changes in astigmatism and shape of total and posterior cornea after nasal versus temporal clear corneal incision (CCI) cataract surgery: a prospective randomized clinical study.

Acronym

Corneal shape changes of total and posterior corneas after nasal versus temporal clear corneal incisions.

Scientific Title

Surgically induced changes in astigmatism and shape of total and posterior cornea after nasal versus temporal clear corneal incision (CCI) cataract surgery: a prospective randomized clinical study.

Scientific Title:Acronym

Corneal shape changes of total and posterior corneas after nasal versus temporal clear corneal incisions.

Region

Japan


Condition

Condition

Cataract

Classification by specialty

Ophthalmology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to compare surgically induced astigmatism (SIA) and shape changes of total and posterior cornea between eyes that underwent nasal clear corneal incisions (CCI) and eyes that underwent temporal CCI in cataract surgery.

Basic objectives2

Bio-equivalence

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

Patients are to undergo examinations at 2 days and at 2, 4, and 8 weeks after surgery.
1) Corneal astigmatism of anterior and posterior corneas (simulated K value of a videokeratography system; Tomey TMS-5)
2) Corneal shape changes of anterior and posterior cornea (average of difference map of TMS-5)

Key secondary outcomes

3) Irregular astigmatism components (asymmetry and higher-order irregularity components)
4) Ocular higher order aberrations (HOAs)
5) Visual acuity and refractive status
6) Wound length and width
7) Pupil diameter
8) Surgical factors


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -but assessor(s) are blinded

Control

Active

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Numbered container method


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

One hundred left eyes of 100 patients with with-the-rule astigmatism of 0.5 D or less were randomly assigned to one of the two groups.

Interventions/Control_2

50 eyes were to undergo nasal CCI and 50 eyes were to undergo temporal CCI.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

One hundred left eyes of 100 patients with with-the-rule astigmatism of 0.5 D or less.

Key exclusion criteria

Exclusion criteria were 1) eyes with any pathology of cornea, optic nerve, and macula; 2) eyes with lens nucleus harder than grade 4 according to the Lens Opacities Classification System III; 3) eyes with a poor mydriasis less than 4.5 mm; 4) eyes with possible zonular weakness, 5) eyes with pseudoexfoliation; 6) eyes with prior history of ocular surgery and inflammation, 7) patients with diabetes; 8) patients who were referred from other hospitals, and 9) patients who had been enrolled in other studies

Target sample size

100


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Ken Hayashi

Organization

Hayashi Eye Hospital

Division name

Department of ophthalmology

Zip code


Address

4-23-35, Hakataekimae, Hakata-ku,Fukuoka, Japan

TEL

092-431-1680

Email

hayashi-ken@hayashi.or.jp


Public contact

Name of contact person

1st name
Middle name
Last name Ken Hayashi

Organization

Hayashi Eye Hospital

Division name

Department of ophthalmology

Zip code


Address

4-23-35, Hakataekimae, Hakata-ku,Fukuoka, Japan

TEL

092-431-1680

Homepage URL


Email

hayashi-ken@hayashi.or.jp


Sponsor or person

Institute

Hayashi Eye Hospital

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

林眼科病院(福岡県)/ Hayashi Eye Hospital(Fukuoka)


Other administrative information

Date of disclosure of the study information

2017 Year 07 Month 26 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 10 Month 26 Day

Date of IRB


Anticipated trial start date

2016 Year 11 Month 21 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2017 Year 07 Month 26 Day

Last modified on

2018 Year 06 Month 22 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000032490


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name